EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluating the Prophylactic and Nephroprotective Effects of Vitamin D and Metformin in Diabetic Nephropathy

Lavanya B Ramegowda iD, Prashant Vishwanath iD, Paramahans V Salimath iD, Manjunath S Shetty iD, Srinath K Marulaiah iD, Shobha C Ramachandra iD, Akila Prashant iD

Oxidative Medicine and Cellular Longevity · 2025

DOI: 10.1155/omcl/5370323 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oxidative Medicine and Cellular Longevity, 2025. Verfasst von Lavanya B Ramegowda und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center of Excellence in Molecular Biology and Regenerative Medicine, Department of Biochemistry, JSS Medical College, JSS Academy of Higher Education…. Hauptthemen laut MEDLINE: Metformin, Diabetic Nephropathies, Vitamin D, Diabetes Mellitus, Experimental. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Diabetic nephropathy (DN), a major complication of diabetes mellitus (DM) and a leading cause of end‐stage renal disease (ESRD) globally, is characterized by oxidative stress (OS), chronic inflammation, and progressive fibrosis. Despite existing treatment options, disease progression remains a challenge. This study evaluates the therapeutic potential of vitamin D, alone and in combination with metformin, in mitigating DN progression in streptozotocin (STZ) induced diabetic rats.

Methods

Male Wister rats were induced with diabetes using a single intraperitoneal injection of STZ and randomized into seven groups. Treatment regimens included vitamin D (5000 or 8000 IU), metformin (250 mg), or a combination, administered over 12 or 21 weeks. Fasting blood glucose (FBG), lipid profiles, renal function markers, and OS indicators were assessed. Renal tissues were examined via histopathological analysis to assess structural changes, and immunohistochemistry (IHC) was performed to evaluate the expression of key proteins involved in inflammation (transforming growth factor–beta [TGF‐β]), fibrosis (VEGF), and OS (nuclear factor erythroid 2‐related factor 2 [Nrf2]), and vitamin D receptor (VDR) signaling.

Results

Vitamin D treatment caused a dose‐dependent decrease in FBG, with the vitamin D and metformin combination therapy achieving the greatest decrease (−49.8%) by week 21. Triglyceride levels were significantly reduced (−50%), while HDL levels remained stable. Combination therapy significantly reduced hydrogen peroxide (H 2 O 2 ) (−36.84%) and nitric oxide (NO) (−14.29%) and enhanced antioxidant enzyme activity: glutathione reductase (GR) (+250%), Superoxide dismutase (SOD) (+11.33%), and Glutathione peroxidase (GPx) (+62.83%). Histological analysis revealed preserved renal architecture and reduced fibrosis in treated groups, particularly in those receiving combination therapy. IHC showed increased VDR and Nrf2 expression, reduced VEGF and TGF‐β levels, reflecting attenuation of inflammation, fibrosis, and oxidative damage.

Conclusion

Vitamin D, particularly in combination with metformin, significantly attenuates DN progression by enhancing metabolic control, reducing OS, and preserving renal function. These findings support its potential as an effective adjunctive therapy in DN management and provide a foundation for future clinical investigations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminDiabetic NephropathiesVitamin DDiabetes Mellitus, ExperimentalAnimalsMaleRatsRats, WistarOxidative StressKidney

Stichwörter der Autor:innen

antioxidant effectsdiabetic nephropathymetforminoxidative stressvitamin D

Substanzen

MetforminVitamin D

Autor:innen und Institutionen

  • Center of Excellence in Molecular Biology and Regenerative Medicine, Department of Biochemistry, JSS Medical College, JSS Academy of Higher Education and Research, Mysuru, Karnataka, India.
  • Special Interest Group on Human Genetics and Rare Disorders, JSS Medical College, JSS Academy of Higher Education and Research, Mysuru, Karnataka, India.
  • Department of Nephrology, JSS Medical College, JSS Academy of Higher Education and Research, Mysuru, Karnataka, India.
  • Department of General Medicine, JSS Medical College, JSS Academy of Higher Education and Research, Mysuru, Karnataka, India.

ORCID-Profile: Lavanya B Ramegowda, Prashant Vishwanath, Paramahans V Salimath, Manjunath S Shetty, Srinath K Marulaiah, Shobha C Ramachandra, Akila Prashant

Förderung

  • Indian Council of Medical Research

Zitieren

APA

B Ramegowda, L., Vishwanath, P., V Salimath, P., S Shetty, M., K Marulaiah, S., C Ramachandra, S., & Prashant, A. (2025). Evaluating the Prophylactic and Nephroprotective Effects of Vitamin D and Metformin in Diabetic Nephropathy. Oxidative Medicine and Cellular Longevity. https://doi.org/10.1155/omcl/5370323

Vancouver

B Ramegowda L, Vishwanath P, V Salimath P, S Shetty M, K Marulaiah S, C Ramachandra S, et al. Evaluating the Prophylactic and Nephroprotective Effects of Vitamin D and Metformin in Diabetic Nephropathy. Oxidative Medicine and Cellular Longevity. 2025. doi:10.1155/omcl/5370323

BibTeX
@article{BRamegowda2025,
  author = {B Ramegowda, Lavanya and Vishwanath, Prashant and V Salimath, Paramahans and S Shetty, Manjunath and K Marulaiah, Srinath and C Ramachandra, Shobha and Prashant, Akila},
  title = {Evaluating the Prophylactic and Nephroprotective Effects of Vitamin D and Metformin in Diabetic Nephropathy},
  journal = {Oxidative Medicine and Cellular Longevity},
  year = {2025},
  doi = {10.1155/omcl/5370323}
}
Kostenlos starten →